ALT vs CVX · rev $5.0K vs P/E 17, rev $118.66B
Altimmune Inc (ALT) versus Chevron Corp (CVX) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Chevron Corp (CVX) is a oil & gas integrated company listed on US. It is led by Mike Wirth.
Latest reported ALT revenue for 2025-09-30 was $5.0K. Net income was -$60.7M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. ALT currently screens at market cap $527.0M.
Latest reported CVX revenue for 2026-06-30 was $118.66B. Net income was $14.28B. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
ALT currently screens at market cap $527.0M. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
Not investment advice. Open the ALT and CVX stock pages for the full models.
Not investment advice.